|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of interleukin-4 and interleukin-10 inmurine collagen-induced arthritis: protective effect of imerleukin-4 and interleukin-10 treatment on cartilage destruction 显示文摘 | Joosten LA Lubberts E Durez P | 2004 | Arthritis Rheum2004，40，： | 1 |
| 2 | Effects of raloxifene treatment on the phenotype of blood monocytes显示文摘 | Boudjeltia K Z Durez P Oberweis D | 2010 | Can J Physiol Pharmacol2010，88，5： | 1 |
| 3 | Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis:protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction显示文摘 | Joosten L A Lubberts E Durez P | 1997 | Arthritis Rheum1997，40，： | 1 |
| 4 | Comparison of methotrexate monotherapy with a combination of metbotrexate and e- tanercept in active,early,moderate to severe rheumatoid arthritis (COMET) :a randomised,double -blind ,parallel treatment trim 显示文摘 | Paul Emery FCB Stephen Hall Patrick Durez | 2008 | Lancet2008，，372： | 1 |
| 5 | Maintenance,reduc-tion,or withdrawal of etanercept after treatment with et-anercept and methotrexate in patients with moderaterheumatoid arthritis(PRESERVE): a randomised con-trolled trial显示文摘 | Smolen JS Nash P Durez P | 2013 | Lancet2013，381，9870： | 1 |
| 6 | Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis; protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction 显示文摘 | Joosten LA Lubberts E Durez P | 1997 | Arthritis Rheu m1997，40，： | 1 |
| 7 | Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis显示文摘 | WEISMAN MH DUREZ P HALLEGUA D | 2006 | J Rheumatol2006，33，1： | 1 |
| 8 | 显示文摘 | Joosten LA Lubberts E Durez P | 1997 | Arthritis Rheum1997，40，2： | 1 |
| 9 | Remission and immune reconstitution after T - cell - depleted stem - cell transplantation for rheumatoid arthritis显示文摘 | Durez P Toungouz M Schandene L | 1998 | Lancet1998，352，9131： | 1 |
| 10 | Role of interleukin-4 and interleukin-10 in murine cillagen-induced arthritis显示文摘 | Joosten L A B Lubbtrts E Durez P | 1997 | Arthritis Rheum1997，40，2： | 1 |
| 11 | One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis:phaseⅡ,dose-finding,double-blind,randomized,placebo-controlled study显示文摘 | Genovese MC Durez P Richards HB | 2014 | J Rheumatol2014，41，3： | 1 |
| 12 | Maintenance,reduction,or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rhcumatoid arthritis (PRESERVE):a randomised controlled trial显示文摘 | Smolen JS Nash P Durez P | | 0，，9870： | 1 |
| 13 | A randomised comparative study of the short termclinical and biological effects of intravenous pulsemethylprednisolone and infliximab in patients withactive rheumatoid arthritis despite methotrexatetreatment显示文摘 | Durez P Nzeusseu Toukap A Lauwerys BR | 2004 | Ann Rheum Dis2004，63，9： | 1 |
| 14 | Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severelong-standing refractory disease:attrition rate and evolution of diseaseactivity 显示文摘 | Vander Cruyssen B Durez P Westhovens R | 2010 | Arthritis Res Ther2010，12，3： | 1 |
| 15 | Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction 显示文摘 | Joosten LAB Lubberts E Durez P | 1997 | Arthritis Rheum1997，40，： | 1 |
| 16 | Rheumatoid arthritis synovial fibroblasts produce a soluble form of the inter- leukin-7 receptor in response to pro-inflammatory cytokines 显示文摘 | Badot V Durez P Van den Eynde B J | 2011 | J Cell Mol Med2011，15，11： | 1 |
| 17 | Dramatic response after an intravenous loading dose of azathioprine in one case of severe and refractory ankglosing sponclylitis显示文摘 | Durez P Horsmans Y | 2000 | Rheumatology2000，39，2： | 1 |
| 18 | Efficacy and safety of secukinumab in patients with rheumatoid arthri- tis : a phase Ⅱ, dose-finding, double blind, randomised, pla- cebo controlled study显示文摘 | Genovese MC Durez P Richards HB | 2013 | Ann Rheum Dis2013，72，6： | 1 |
| 19 | One-year Ef- ficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis : Phase Ⅱ, Dose-finding, Doub- le-blind, Randomized, Placebo-controlled Study 显示文摘 | Genovese MC Durez P Richards HB | 2014 | J Rheumatol2014，41，3： | 1 |
| 20 | Efleets of raloxifenetreatment on the phenotype of blood monocyles显示文摘 | Boudjcltia K Z Durez P Oberweis D | 2010 | Can J PhysiolPharmacol2010，88，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员